We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£325.00
It has never been this cheap. We have no record of a lower price.
£325 today · cheaper than every other day in the last 3 months
Multiple Myeloma Therapeutics in Africa 2013-2018 Outlook
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 32 days · 32 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 32 days • 1 price levels
Price Analysis
Most common price: £325 (32 days, 100.0%)
Price range: £325 - £325
Price levels: 1 different prices over 32 days
Description
Key Features
Provides econometric estimates for potential industry earnings (P.I.E.) in millions of U.S. dollars for each reported year.
Includes comparative benchmarks showing the percent share each country holds of the region and the globe.
Utilizes econometric models to project fundamental economic dynamics within and across individual countries.
Offers detailed outlook data for multiple myeloma therapeutics in Africa covering the period from 2013 to 2018.
Product Specifications
- Format
- paperback
- ASIN
- B00EA0H5QI
- Domain
- Amazon UK
- Release Date
- 17 July 2013
- Listed Since
- 01 August 2013
Similar Products You Might Like
The 2023-2028 Outlook for Multiple Myeloma Treatments in China
The 2025-2030 World Outlook for Chemotherapy and Other Multiple Myeloma Therapeutics
Price unavailable
Lymphoma Therapeutics in Africa: 2013-2018 Outlook Study
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa & the Middle East
CML Treatment Outlook 2023-2028 - US Zip Code Analysis
The 2016-2021 Outlook for Hematology and Oncology Products in India
The 2013-2018 Outlook for Melanoma Therapeutics in India
The 2016-2021 Outlook for Hematology and Oncology Products in the United States
The 2016-2021 Outlook for Hematology and Oncology Products in Greater China
NSCLC Therapeutics Outlook in Asia (2013-2018) Study
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
Non-Hodgkin Lymphoma Chemotherapy Outlook in India 2023-2028
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in the United States
The 2023-2028 Outlook for Bone Marrow Autologous Cell Therapies in the United States
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
The 2023-2028 Outlook for Myeloproliferative Disorder Drugs in India
Cancer Therapies in Asia 2016-2021 Outlook - Econometric Study
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in China
